Clinical Trials · NCT06802081
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- The Cleveland Clinic
- Enrollment
- 100
- Start date
- Apr 2025
- Locations
- 1 site, United States
- Primary endpoint
- AFib burden